• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因子 Va 和蛋白 S 在激活蛋白 C/蛋白 S/因子 Va 失活复合物形成中的作用。

The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.

机构信息

Centre for Haematology, Imperial College London, London, UK.

出版信息

J Thromb Haemost. 2019 Dec;17(12):2056-2068. doi: 10.1111/jth.14594. Epub 2019 Aug 9.

DOI:10.1111/jth.14594
PMID:31364267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6916587/
Abstract

BACKGROUND

Activated protein C (APC)-mediated inactivation of factor (F)Va is greatly enhanced by protein S. For inactivation to occur, a trimolecular complex among FVa, APC, and protein S must form on the phospholipid membrane. However, direct demonstration of complex formation has proven elusive.

OBJECTIVES

To elucidate the nature of the phospholipid-dependent interactions among APC, protein S, and FVa.

METHODS

We evaluated binding of active site blocked APC to phospholipid-coated magnetic beads in the presence and absence of protein S and/or FVa. The importance of protein S and FV residues were evaluated functionally.

RESULTS

Activated protein C alone bound weakly to phospholipids. Protein S mildly enhanced APC binding to phospholipid surfaces, whereas FVa did not. However, FVa together with protein S enhanced APC binding (>14-fold), demonstrating formation of an APC/protein S/FVa complex. C4b binding protein-bound protein S failed to enhance APC binding, agreeing with its reduced APC cofactor function. Protein S variants (E36A and D95A) with reduced APC cofactor function exhibited essentially normal augmentation of APC binding to phospholipids, but diminished APC/protein S/FVa complex formation, suggesting involvement in interactions dependent upon FVa. Similarly, FVa (W1920R), an APC-resistant FV variant, also did not efficiently incorporate into the trimolecular complex as efficiently as wild-type FVa. FVa inactivation assays suggested that the mutation impairs its affinity for phospholipid membranes and with protein S within the complex.

CONCLUSIONS

FVa plays a central role in the formation of its inactivation complex. Furthermore, membrane proximal interactions among FVa, APC, and protein S are essential for its cofactor function.

摘要

背景

蛋白 S 极大地增强了激活蛋白 C(APC)对因子(F)Va 的失活作用。为了发生失活作用,FVa、APC 和蛋白 S 之间的三聚体复合物必须在磷脂膜上形成。然而,复合物形成的直接证明一直难以实现。

目的

阐明 APC、蛋白 S 和 FVa 之间依赖于磷脂的相互作用的性质。

方法

我们评估了活性位点被阻断的 APC 在存在和不存在蛋白 S 和/或 FVa 的情况下与磷脂包被的磁性珠的结合。通过功能评估来评估蛋白 S 和 FV 残基的重要性。

结果

单独的激活蛋白 C 与磷脂的结合较弱。蛋白 S 轻度增强 APC 与磷脂表面的结合,而 FVa 则没有。然而,FVa 与蛋白 S 一起增强 APC 结合(>14 倍),表明形成 APC/蛋白 S/FVa 复合物。C4b 结合蛋白结合的蛋白 S 未能增强 APC 结合,这与其 APC 辅助因子功能降低一致。具有降低 APC 辅助因子功能的蛋白 S 变体(E36A 和 D95A)表现出基本正常的 APC 结合到磷脂上的增强,但 APC/蛋白 S/FVa 复合物的形成减少,表明其参与了依赖 FVa 的相互作用。同样,APC 抗性 FV 变体(W1920R)也不能像野生型 FVa 那样有效地将 APC 结合到三聚体复合物中。FVa 失活测定表明,该突变损害了其与磷脂膜和复合物内蛋白 S 的亲和力。

结论

FVa 在其失活复合物的形成中起着核心作用。此外,FVa、APC 和蛋白 S 之间的膜近端相互作用对于其辅助因子功能至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/7607a0738f29/JTH-17-2056-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/1bd77729939d/JTH-17-2056-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/bedb8f379baa/JTH-17-2056-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/e138712d712f/JTH-17-2056-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/a7db35b7b1bf/JTH-17-2056-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/1c5b40645311/JTH-17-2056-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/4f910a2b0a2a/JTH-17-2056-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/7607a0738f29/JTH-17-2056-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/1bd77729939d/JTH-17-2056-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/bedb8f379baa/JTH-17-2056-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/e138712d712f/JTH-17-2056-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/a7db35b7b1bf/JTH-17-2056-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/1c5b40645311/JTH-17-2056-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/4f910a2b0a2a/JTH-17-2056-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5866/6916587/7607a0738f29/JTH-17-2056-g007.jpg

相似文献

1
The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.因子 Va 和蛋白 S 在激活蛋白 C/蛋白 S/因子 Va 失活复合物形成中的作用。
J Thromb Haemost. 2019 Dec;17(12):2056-2068. doi: 10.1111/jth.14594. Epub 2019 Aug 9.
2
Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.凝血因子V中各个活化蛋白C切割位点区域在因子Va失活和因子Xa激活中的重要性。
Eur J Biochem. 1999 Feb;260(1):64-75. doi: 10.1046/j.1432-1327.1999.00137.x.
3
Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S.FVa 中的新型 APC 裂解位点为 APC 及其辅因子蛋白 S 的作用机制提供了新的见解。
J Thromb Haemost. 2010 Jan;8(1):129-36. doi: 10.1111/j.1538-7836.2009.03657.x. Epub 2009 Oct 23.
4
Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va.凝血酶原对活化蛋白C介导的凝血因子Va的个体切割作用的影响。
J Biol Chem. 2008 Mar 14;283(11):6648-55. doi: 10.1074/jbc.M708036200. Epub 2008 Jan 15.
5
Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.凝血酶原氨基末端区域有助于保护凝血因子Va免受活化蛋白C的蛋白水解失活作用。
Thromb Haemost. 2009 Jan;101(1):55-61. doi: 10.1160/th08-07-0491.
6
Enhanced rate of cleavage at Arg-306 and Arg-506 in coagulation factor Va by Gla domain-mutated human-activated protein C.Gla结构域突变的人活化蛋白C对凝血因子Va中精氨酸-306和精氨酸-506处切割速率的增强作用。
J Biol Chem. 2004 Nov 12;279(46):47528-35. doi: 10.1074/jbc.M407366200. Epub 2004 Aug 27.
7
The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.精氨酸306突变为丙氨酸以及精氨酸506突变为谷氨酰胺对活化蛋白C和蛋白S使重组人因子Va失活的影响。
Protein Sci. 1997 Sep;6(9):2016-27. doi: 10.1002/pro.5560060922.
8
Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain.蛋白 S 激活蛋白 C 辅因子功能:EGF1 样结构域中 Asp95 起关键作用。
Blood. 2010 Jun 10;115(23):4878-85. doi: 10.1182/blood-2009-11-256610. Epub 2010 Mar 22.
9
Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.凝血因子Xa和蛋白S在因子Va中涉及493 - 506位残基的结合位点。
Protein Sci. 1996 Sep;5(9):1883-9. doi: 10.1002/pro.5560050914.
10
Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.鉴定人凝血因子Va的表面表位,这些表位对于与活化蛋白C和肝素的相互作用很重要。
J Biol Chem. 2008 Aug 15;283(33):22573-81. doi: 10.1074/jbc.M801724200. Epub 2008 Jun 2.

引用本文的文献

1
The common VTE-protective G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding.凝血因子V常见的VTE保护性G单倍型增加了凝血因子V短链、组织因子途径抑制物(TFPI)的功能以及出血风险。
Blood Adv. 2025 Jan 14;9(1):132-142. doi: 10.1182/bloodadvances.2024014020.
2
Factor V variants in bleeding and thrombosis.出血和血栓形成中的凝血因子V变体
Res Pract Thromb Haemost. 2024 Jan 26;8(1):102330. doi: 10.1016/j.rpth.2024.102330. eCollection 2024 Jan.
3
TFPIα anticoagulant function is highly dependent on protein S in vivo.TFPIα 的抗凝功能在体内高度依赖于蛋白质 S。

本文引用的文献

1
Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.新型因子 V 异构体、组织因子途径抑制物α 和蛋白 S 对凝血的调控作用的新见解。
J Thromb Haemost. 2017 Jul;15(7):1241-1250. doi: 10.1111/jth.13665.
2
Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.因子V具有针对凝血早期阶段的抗凝辅因子活性。
J Biol Chem. 2017 Jun 2;292(22):9335-9344. doi: 10.1074/jbc.M116.769570. Epub 2017 Apr 18.
3
Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
Sci Adv. 2024 Feb 2;10(5):eadk5836. doi: 10.1126/sciadv.adk5836.
4
Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations.存在 A2086D 和 W1920R 突变导致的因子 V 相关抗凝机制受损和深静脉血栓形成。
Blood Adv. 2023 Jun 27;7(12):2831-2842. doi: 10.1182/bloodadvances.2022008918.
蛋白S和因子V在活化蛋白C对血小板微粒凝血的调节作用中。
Thromb Res. 2014 Jul;134(1):144-52. doi: 10.1016/j.thromres.2014.04.031. Epub 2014 May 2.
4
TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.蛋白S的组织因子途径抑制物(TFPI)辅因子功能:蛋白S性激素结合球蛋白样结构域的关键作用。
Blood. 2014 Jun 19;123(25):3979-87. doi: 10.1182/blood-2014-01-551812. Epub 2014 Apr 16.
5
Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden.新型 FV 突变(W1920R、FVNara)与严重深静脉血栓形成相关,与 FVLeiden 相比,对 APC 的抵抗作用更强。
Blood. 2014 Apr 10;123(15):2420-8. doi: 10.1182/blood-2013-10-530089. Epub 2014 Feb 12.
6
Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.血浆蛋白 S 残基 37-50 介导其与因子 Va 的结合并抑制血液凝固。
Thromb Haemost. 2013 Aug;110(2):275-82. doi: 10.1160/TH12-12-0953. Epub 2013 May 23.
7
Combined deficiency of coagulation factors V and VIII: an update.凝血因子 V 和 VIII 联合缺乏症:更新。
Semin Thromb Hemost. 2013 Sep;39(6):613-20. doi: 10.1055/s-0033-1349223. Epub 2013 Jul 12.
8
Contribution of factor VIII light-chain residues 2007-2016 to an activated protein C-interactive site.VIII 因子轻链残基 2007-2016 对活化蛋白 C 相互作用位点的贡献。
Thromb Haemost. 2013 Feb;109(2):187-98. doi: 10.1160/TH12-08-0561. Epub 2012 Dec 6.
9
The anticoagulant function of coagulation factor V.凝血因子 V 的抗凝功能。
Thromb Haemost. 2012 Jan;107(1):15-21. doi: 10.1160/TH11-06-0431. Epub 2011 Nov 24.
10
Activated protein C cofactor function of protein S: a novel role for a γ-carboxyglutamic acid residue.蛋白 S 激活蛋白 C 辅因子功能:γ-羧基谷氨酸残基的新作用。
Blood. 2011 Jun 16;117(24):6685-93. doi: 10.1182/blood-2010-11-317099. Epub 2011 Apr 20.